Compare Innodata Inc (INOD) vs Mesoblast Limited (MESO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Innodata Inc vs Mesoblast Limited — how do they compare? Innodata Inc trades at $61.65 (market cap $2.05B), while Mesoblast Limited trades at $17.04 (market cap $2.21B). The key difference: Innodata Inc and Mesoblast Limited are close in size by market cap, and Mesoblast Limited is trading nearer its 52-week high, Innodata Inc nearer its low. Which is the better fit depends on your goals.
| INOD | MESO | |
|---|---|---|
Market Cap | $2.05B | $2.21B |
Sector | Technology | Technology |
52-Week High | $121.50 | $20.96 |
52-Week Low | $34.45 | $12.88 |
Enterprise Value | $1.80B | $2.21B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Innodata Inc
Innodata is a global data engineering company that provides solutions for training AI models. It helps enterprises solve complex data challenges through high-quality data annotation and digital transformation.
Read more on INOD →About Mesoblast Limited
Mesoblast Limited is a global leader in allogeneic cellular medicines. The company develops innovative, commercially-ready mesenchymal lineage cell (MLC) technology for the treatment of various inflammatory and cardiovascular conditions. Their pipeline focuses on leveraging the anti-inflammatory, tissue repair, and immune-modulating properties of these cells for diseases with high unmet medical needs, such as acute graft versus host disease (aGVHD) and chronic heart failure.
Read more on MESO →
